The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
 
Karen A. Autio
Research Funding - BIND Therapeutics
 
Jorge A. Garcia
Honoraria - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; GlaxoSmithKline; Lpath; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex
 
Lowell L. Hart
Research Funding - BIND Therapeutics
 
Matthew I. Milowsky
Research Funding - Astellas Pharma (Inst); BIND Therapeutics (Inst); Cerulean Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst)
 
Edwin M. Posadas
Research Funding - BIND Therapeutics
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Jason Mark Summa
Employment - BIND Therapeutics
Stock and Other Ownership Interests - BIND Therapeutics
 
Hagop Youssoufian
Employment - BIND Therapeutics
Stock and Other Ownership Interests - BIND Therapeutics
 
Howard I. Scher
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BIND Therapeutics; Blue Earth Diagnostics; Bristol-Myers Squibb; Chugai Pharma; Endocyte; Ferring; Genentech; Janssen; Med IQ; Medivation; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; BIND Therapeutics; Bristol-Myers Squibb; Celgene; Endocyte; Ferring; Genentech; Janssen; Medivation; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group
 
Robert Dreicer
Honoraria - Astellas Pharma
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; BIND Biosciences; Dendreon; Medivation; Merck; Millennium; Roche
Research Funding - Progenics (Inst)